Analysts at Nomura initiated coverage on shares of Tetralogic Pharmaceuticals Corporation (NASDAQ:TLOG) in a research note on Thursday, June 26th. They set a “buy” rating and a $9.00 price target on the stock. Four equities research analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and an average target price of $12.50. TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) … Continue reading Stock Runners : TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), EMC Corporation (NYSE:EMC), Nabors Industries Ltd. (NYSE:NBR), BioMed Realty Trust (NYSE:BMR), Old Republic International (NYSE:ORI)